Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
TOBACCO-FREE KIDS ACTION FUND

2. Address

Address1
1400 I Street NW
 Address2
​Suite 1200
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Abyot Wondimu
​2022965469
​accounting@tobaccofreekids.org
5. Senate ID#
​401106380-51237
7. Client Name Self Check if client is a state or local government or instrumentality
​TOBACCO-FREE KIDS ACTION FUND
6. House ID#
​454430001
TYPE OF REPORT 8. Year
​2025
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​480,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Abyot Wondimu
 Date
10/20/2025 3:54:04 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

Lobbying Report: July 1st -September 30th, 2025 (Action Fund) 

Federal (under tobacco issue code)  
Legislation:  
Comprehensive Tobacco Control Legislation
H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act
H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act
H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act
FY 26 Senate State, Foreign Operations, and Related Programs
H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act
S. 2064, Helping Tobacco Users Quit Act
H.R. 1, One Big Beautiful Bill Act
H. R. 901 (118th Congress), Disposable ENDS Product Enforcement Act of 2023
H.R. 2111, To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
H.R. 4404, the Hookah Clarification Act
H.R. 9425 (118th Congress), the Tobacco User Fee Modernization Act of 2024
S. 819/H.R. 1798, End Tobacco Loopholes Act
S. 2171/H.R.3855, a bill to prohibit smoking on premises of Veterans Health Administration facilities

Issues:
CDC FY 25 state National Tobacco Control Program grants
CDC Office on Smoking and Health funding
Congressional Caucus to Prevent Youth Vaping
Congressional efforts to reduce e-cigarette and tobacco use
FDA authority over tobacco products
FDA authorization of tobacco products
FDA destruction authority
FDA enforcement against unauthorized e-cigarettes
FDA multiagency task force to combat the distribution and sale of illegal e-cigarettes
FDA tobacco user fees
FDA track and trace system for tobacco products
GAO report on federal efforts to address unauthorized e-cigarettes
HHS reorganization
FDAs proposed rule to prohibit menthol cigarettes
FDA Proposed rule to set a maximum nicotine level for cigarettes
Tobacco cessation in general
U.S. Preventive Services Task Force

Agencies Visited:  
Food and Drug Administration 
US House of Representatives  
US Senate  

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Brian J
Hickey
​
Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002
Luke C.
George
​
Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

GHAI Overdose Initiative (under healthcare issue code):
Legislation:
FY 26 Appropriations bills
Modernizing Opioid Treatment Access Act
PEER Support Act
S. 1165/H. R. 2586, Reentry Act
S. 1720/H.R. 1510, Due Process Continuity of Care Act
S. 2697, Due Process Continuity of Care Act
SUPPORT for Patients and Communities Reauthorization Act

Issues: 
Medicaid prior authorization requirements
Access to medications for opioid use disorder
Overdose prevention
Racial disparities in overdose deaths

Agencies Visited: 
Centers for Disease Control and Prevention
US House of Representatives 
US Senate



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elizabeth
Jones
​
​
Madison
Fields
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​HCR
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
Campaign for Tobacco-Free Kids
1400 I Street NW Suite # 1200
Washington DC 20005 USA
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)